<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31529970</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>39</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Biochemistry</Title><ISOAbbreviation>Biochemistry</ISOAbbreviation></Journal><ArticleTitle>Using Tetracysteine-Tagged TDP-43 with a Biarsenical Dye To Monitor Real-Time Trafficking in a Cell Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>4086</StartPage><EndPage>4095</EndPage><MedlinePgn>4086-4095</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.biochem.9b00592</ELocationID><Abstract><AbstractText>TAR DNA-binding protein 43 (TDP-43) has been identified as the major constituent of the proteinaceous inclusions that are characteristic of most forms of amyotrophic lateral sclerosis (ALS) and ubiquitin positive frontotemporal lobar degeneration (FTLD). Wild type TDP-43 inclusions are a pathological hallmark of &gt;95% of patients with sporadic ALS and of the majority of familial ALS cases, and they are also found in a significant proportion of FTLD cases. ALS is the most common form of motor neuron disease, characterized by progressive weakness and muscular wasting, and typically leads to death within a few years of diagnosis. To determine how the translocation and misfolding of TDP-43 contribute to ALS pathogenicity, it is crucial to define the dynamic behavior of this protein within the cellular environment. It is therefore necessary to develop cell models that allow the location of the protein to be defined. We report the use of TDP-43 with a tetracysteine tag for visualization using fluorogenic biarsenical compounds and show that this model displays features of ALS observed in other cell models. We also demonstrate that this labeling procedure enables live-cell imaging of the translocation of the protein from the nucleus into the cytosol.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Janice S W</ForeName><Initials>JSW</Initials><AffiliationInfo><Affiliation>Centre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanspal</LastName><ForeName>Maya A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matharu</LastName><ForeName>Naunehal S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Centre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barros</LastName><ForeName>Teresa P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Centre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esbj&#xf6;rner</LastName><ForeName>Elin K</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0002-1253-6342</Identifier><AffiliationInfo><Affiliation>Department of Biology and Biological Engineering, Division of Chemical Biology , Chalmers University of Technology , Kemiv&#xe4;gen 10 , 412 96 Gothenburg , Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute , Wollongong , NSW 2522 , Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Horizons and School of Chemistry and Molecular Bioscience, Faculty of Science Medicine and Health , University of Wollongong , Northfields Avenue , Wollongong , NSW 2522 , Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yerbury</LastName><ForeName>Justin J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0003-2528-7039</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute , Wollongong , NSW 2522 , Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Horizons and School of Chemistry and Molecular Bioscience, Faculty of Science Medicine and Health , University of Wollongong , Northfields Avenue , Wollongong , NSW 2522 , Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobson</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Centre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumita</LastName><ForeName>Janet R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-3887-4964</Identifier><AffiliationInfo><Affiliation>Centre for Misfolding Diseases, Department of Chemistry , University of Cambridge , Lensfield Road , Cambridge CB2 1EW , U.K.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>094425/Z/10/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochemistry</MedlineTA><NlmUniqueID>0370623</NlmUniqueID><ISSNLinking>0006-2960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C113276">4',5'-bis(1,3,2-dithioarsolan-2-yl)fluorescein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005452">Fluoresceins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009942">Organometallic Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI="D003545">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003600" MajorTopicYN="N">Cytosol</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018274" MajorTopicYN="N">Electroporation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005452" MajorTopicYN="N">Fluoresceins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061848" MajorTopicYN="N">Optical Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009942" MajorTopicYN="N">Organometallic Compounds</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016324" MajorTopicYN="Y">Sequence Tagged Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059008" MajorTopicYN="N">Time-Lapse Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors
declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31529970</ArticleId><ArticleId IdType="pmc">PMC6775541</ArticleId><ArticleId IdType="doi">10.1021/acs.biochem.9b00592</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arai T.; Hasegawa M.; Akiyama H.; Ikeda K.; Nonaka T.; Mori H.; Mann D.; Tsuchiya K.; Yoshida M.; Hashizume Y.; Oda T. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602&#x2013;611. 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T.; Hasegawa M.; Nonoka T.; Kametani F.; Yamashita M.; Hosokawa M.; Niizato K.; Tsuchiya K.; Kobayashi Z.; Ikeda K.; Yoshida M.; Onaya M.; Fujishiro H.; Akiyama H. (2010) Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology 30, 170&#x2013;181. 10.1111/j.1440-1789.2009.01089.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01089.x</ArticleId><ArticleId IdType="pubmed">20102522</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M.; Sampathu D. M.; Kwong L. K.; Truax A. C.; Micsenyi M. C.; Chou T. T.; Bruce J.; Schuck T.; Grossman M.; Clark C. M.; McCluskey L. F.; Miller B. L.; Masliah E.; Mackenzie I. R.; Feldman H.; Feiden W.; Kretzschmar H. A.; Trojanowski J. Q.; Lee V. M. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133. 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P.; Lambert-Smith I. A.; Bean D. M.; Freer R.; Cid F.; Tartaglia G. G.; Saunders D. N.; Wilson M. R.; Oliver S. G.; Morimoto R. I.; Dobson C. M.; Vendruscolo M.; Favrin G.; Yerbury J. J. (2017) Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc. Natl. Acad. Sci. U. S. A. 114, E3935&#x2013;E3943. 10.1073/pnas.1613854114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1613854114</ArticleId><ArticleId IdType="pmc">PMC5441770</ArticleId><ArticleId IdType="pubmed">28396410</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E.; Baralle F. E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276, 36337&#x2013;36343. 10.1074/jbc.M104236200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104236200</ArticleId><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N. E.; Lambert-Smith I. A.; Warraich S. T.; Blair I. P.; Saunders D. N.; Hatters D. M.; Yerbury J. J. (2015) Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 5, 13416.10.1038/srep13416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13416</ArticleId><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P.; Newcombe J.; Troakes C.; Simone R.; Chen Y. R.; Patani R.; Sidle K. (2016) In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol. Dis. 96, 236&#x2013;247. 10.1016/j.nbd.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5113659</ArticleId><ArticleId IdType="pubmed">27590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R.; Capitini C.; Fani G.; Dobson C. M.; Cecchi C.; Chiti F. (2016) Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies. J. Biol. Chem. 291, 19437&#x2013;19448. 10.1074/jbc.M116.737726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.737726</ArticleId><ArticleId IdType="pmc">PMC5016682</ArticleId><ArticleId IdType="pubmed">27445339</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin B. A.; Adams S. R.; Tsien R. Y. (1998) Specific covalent labeling of recombinant protein molecules inside live cells. Science 281, 269&#x2013;272. 10.1126/science.281.5374.269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5374.269</ArticleId><ArticleId IdType="pubmed">9657724</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin B. R.; Giepmans B. N.; Adams S. R.; Tsien R. Y. (2005) Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity. Nat. Biotechnol. 23, 1308&#x2013;1314. 10.1038/nbt1136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1136</ArticleId><ArticleId IdType="pubmed">16155565</ArticleId></ArticleIdList></Reference><Reference><Citation>Giepmans B. N.; Adams S. R.; Ellisman M. H.; Tsien R. Y. (2006) The fluorescent toolbox for assessing protein location and function. Science 312, 217&#x2013;224. 10.1126/science.1124618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1124618</ArticleId><ArticleId IdType="pubmed">16614209</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberti M. J.; Bertoncini C. W.; Klement R.; Jares-Erijman E. A.; Jovin T. M. (2007) Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein. Nat. Methods 4, 345&#x2013;351. 10.1038/nmeth1026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth1026</ArticleId><ArticleId IdType="pubmed">17351621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann C.; Gaietta G.; Zurn A.; Adams S. R.; Terrillon S.; Ellisman M. H.; Tsien R. Y.; Lohse M. J. (2010) Fluorescent labeling of tetracysteine-tagged proteins in intact cells. Nat. Protoc. 5, 1666&#x2013;1677. 10.1038/nprot.2010.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2010.129</ArticleId><ArticleId IdType="pmc">PMC3086663</ArticleId><ArticleId IdType="pubmed">20885379</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman H.; Wirth A. J.; Gruebele M. (2016) ReAsH as a quantitative probe of in-cell protein dynamics. Biochemistry 55, 1968&#x2013;1976. 10.1021/acs.biochem.5b01336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.5b01336</ArticleId><ArticleId IdType="pubmed">26959408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignatova Z.; Gierasch L. M. (2004) Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling. Proc. Natl. Acad. Sci. U. S. A. 101, 523&#x2013;528. 10.1073/pnas.0304533101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0304533101</ArticleId><ArticleId IdType="pmc">PMC327180</ArticleId><ArticleId IdType="pubmed">14701904</ArticleId></ArticleIdList></Reference><Reference><Citation>Irtegun S.; Wood R.; Lackovic K.; Schweiggert J.; Ramdzan Y. M.; Huang D. C.; Mulhern T. D.; Hatters D. M. (2014) A biosensor of SRC family kinase conformation by exposable tetracysteine useful for cell-based screening. ACS Chem. Biol. 9, 1426&#x2013;1431. 10.1021/cb500242q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb500242q</ArticleId><ArticleId IdType="pubmed">24828008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramdzan Y. M.; Nisbet R. M.; Miller J.; Finkbeiner S.; Hill A. F.; Hatters D. M. (2010) Conformation sensors that distinguish monomeric proteins from oligomers in live cells. Chem. Biol. 17, 371&#x2013;379. 10.1016/j.chembiol.2010.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2010.03.011</ArticleId><ArticleId IdType="pmc">PMC3564667</ArticleId><ArticleId IdType="pubmed">20416508</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberti M. J.; Jovin T. M.; Jares-Erijman E. (2011) Confocal fluorescence anisotropy and FRAP imaging of alpha-synuclein amyloid aggregates in living cells. PLoS One 6, e23338.10.1371/journal.pone.0023338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023338</ArticleId><ArticleId IdType="pmc">PMC3152574</ArticleId><ArticleId IdType="pubmed">21858077</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T.; Arai T.; Buratti E.; Baralle F. E.; Akiyama H.; Hasegawa M. (2009) Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett. 583, 394&#x2013;400. 10.1016/j.febslet.2008.12.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.12.031</ArticleId><ArticleId IdType="pubmed">19111550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T.; Masuda-Suzukake M.; Arai T.; Hasegawa Y.; Akatsu H.; Obi T.; Yoshida M.; Murayama S.; Mann D. M.; Akiyama H.; Hasegawa M. (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 4, 124&#x2013;134. 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E.; Neumann M.; Tahirovic S.; Rodde R.; Dormann D.; Haass C. (2012) Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J. Biol. Chem. 287, 23079&#x2013;23094. 10.1074/jbc.M111.328757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.328757</ArticleId><ArticleId IdType="pmc">PMC3391091</ArticleId><ArticleId IdType="pubmed">22563080</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L.; Bilgutay A.; Zhang Y.-J.; Vanderwyde T.; Citro A.; Mehta T.; Zaarur N.; McKee A.; Bowser R.; Sherman M.; Petrucelli L.; Wolozin B. (2010) Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 5, e13250.10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C.; Bassell G. J.; Rossoll W. (2012) The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum. Mol. Genet. 21, 3703&#x2013;3718. 10.1093/hmg/dds205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds205</ArticleId><ArticleId IdType="pmc">PMC3406762</ArticleId><ArticleId IdType="pubmed">22641816</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T.; Kametani F.; Arai T.; Akiyama H.; Hasegawa M. (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 18, 3353&#x2013;3364. 10.1093/hmg/ddp275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp275</ArticleId><ArticleId IdType="pubmed">19515851</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E. L.; Vance C.; Nishimura A. L.; Lee Y. B.; Chen H. J.; Urwin H.; Sardone V.; Mitchell J. C.; Rogelj B.; Rubinsztein D. C.; Shaw C. E. (2014) Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 127, 1263&#x2013;1278. 10.1242/jcs.140087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L. M.; Kwong L. K.; Xu Y.; Truax A. C.; Uryu K.; Neumann M.; Clark C. M.; Elman L. B.; Miller B. L.; Grossman M.; McCluskey L. F.; Trojanowski J. Q.; Lee V. M. (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 173, 182&#x2013;194. 10.2353/ajpath.2008.080003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080003</ArticleId><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W.; Chen Y.; Zhou X.; Kar A.; Ray P.; Chen X.; Rao E. J.; Yang M.; Ye H.; Zhu L.; Liu J.; Xu M.; Yang Y.; Wang C.; Zhang D.; Bigio E. H.; Mesulam M.; Shen Y.; Xu Q.; Fushimi K.; Wu J. Y. (2011) An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol. 18, 822&#x2013;830. 10.1038/nsmb.2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2053</ArticleId><ArticleId IdType="pmc">PMC3357956</ArticleId><ArticleId IdType="pubmed">21666678</ArticleId></ArticleIdList></Reference><Reference><Citation>Peled S.; Sade D.; Bram Y.; Porat Z.; Kreiser T.; Mimouni M.; Lichtenstein A.; Segal D.; Gazit E. (2017) Single cell imaging and quantification of TDP-43 and alpha-synuclein intercellular propagation. Sci. Rep. 7, 544.10.1038/s41598-017-00657-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00657-z</ArticleId><ArticleId IdType="pmc">PMC5428807</ArticleId><ArticleId IdType="pubmed">28373710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalevich J.; Langford D. (2013) Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology. Methods Mol. Biol. 1078, 9&#x2013;21. 10.1007/978-1-62703-640-5_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-640-5_2</ArticleId><ArticleId IdType="pmc">PMC5127451</ArticleId><ArticleId IdType="pubmed">23975817</ArticleId></ArticleIdList></Reference><Reference><Citation>Limbocker R.; Chia S.; Ruggeri F. S.; Perni M.; Cascella R.; Heller G. T.; Meisl G.; Mannini B.; Habchi J.; Michaels T. C. T.; Challa P. K.; Ahn M.; Casford S. T.; Fernando N.; Xu C. K.; Kloss N. D.; Cohen S. I. A.; Kumita J. R.; Cecchi C.; Zasloff M.; Linse S.; Knowles T. P. J.; Chiti F.; Vendruscolo M.; Dobson C. M. (2019) Trodusquemine enhances A beta(42) aggregation but suppresses its toxicity by displacing oligomers from cell membranes. Nat. Commun. 10, 225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6333784</ArticleId><ArticleId IdType="pubmed">30644384</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L.; Lin A. Y.; Ebata A.; Boon J. Y.; Reid W.; Xu Y. F.; Kobrin K.; Murphy G. J.; Petrucelli L.; Wolozin B. (2014) ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J. Neurosci. 34, 4167&#x2013;4174. 10.1523/JNEUROSCI.2350-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2350-13.2014</ArticleId><ArticleId IdType="pmc">PMC3960463</ArticleId><ArticleId IdType="pubmed">24647938</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C. M.; Cenik B.; Sephton C. F.; Dries D. R.; Mayer P. 3rd; Good S. K.; Johnson B. A.; Herz J.; Yu G. (2011) TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell. Biol. 31, 1098&#x2013;1108. 10.1128/MCB.01279-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler M. S.; Strobel B.; Freischmidt A.; Helferich A. M.; Kappel J.; Brewer B. M.; Li D.; Thal D. R.; Walther P.; Ludolph A. C.; Danzer K. M.; Weishaupt J. H. (2015) TDP-43 is intercellularly transmitted across axon terminals. J. Cell Biol. 211, 897&#x2013;911. 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eersel J.; Ke Y. D.; Gladbach A.; Bi M.; Gotz J.; Kril J. J.; Ittner L. M. (2011) Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons. PLoS One 6, e22850.10.1371/journal.pone.0022850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022850</ArticleId><ArticleId IdType="pmc">PMC3146516</ArticleId><ArticleId IdType="pubmed">21829535</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita M.; Nonaka T.; Hirai S.; Miwa A.; Okado H.; Arai T.; Hosokawa M.; Akiyama H.; Hasegawa M. (2014) Distinct pathways leading to TDP-43-induced cellular dysfunctions. Hum. Mol. Genet. 23, 4345&#x2013;4356. 10.1093/hmg/ddu152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu152</ArticleId><ArticleId IdType="pubmed">24698978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. J.; Xu Y. F.; Cook C.; Gendron T. F.; Roettges P.; Link C. D.; Lin W. L.; Tong J.; Castanedes-Casey M.; Ash P.; Gass J.; Rangachari V.; Buratti E.; Baralle F.; Golde T. E.; Dickson D. W.; Petrucelli L. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U. S. A. 106, 7607&#x2013;7612. 10.1073/pnas.0900688106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. (2012) Regulated protein aggregation: stress granules and neurodegeneration. Mol. Neurodegener. 7, 56.10.1186/1750-1326-7-56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-56</ArticleId><ArticleId IdType="pmc">PMC3519755</ArticleId><ArticleId IdType="pubmed">23164372</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C. M.; Cenik B.; Sephton C. F.; Johnson B. A.; Herz J.; Yu G. (2012) TDP-43 aggregation in neurodegeneration: are stress granules the key?. Brain Res. 1462, 16&#x2013;25. 10.1016/j.brainres.2012.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.032</ArticleId><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi S.; Kabuta T.; Nagai Y.; Tsuchiya Y.; Akiyama H.; Wada K. (2013) TDP-43 associates with stalled ribosomes and contributes to cell survival during cellular stress. J. Neurochem. 126, 288&#x2013;300. 10.1111/jnc.12194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12194</ArticleId><ArticleId IdType="pubmed">23398327</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C.; Zennaro E.; Fallini C.; Weber M.; Sommacal A.; Buratti E.; Silani V.; Ratti A. (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 111, 1051&#x2013;1061. 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L.; Lee V. M.; Trojanowksi J. Q.; Van Deerlin V. M.; Lee E. B.; Bonini N. M. (2014) Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72. J. Neuropathol. Exp. Neurol. 73, 837&#x2013;845. 10.1097/NEN.0000000000000102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000102</ArticleId><ArticleId IdType="pmc">PMC4149258</ArticleId><ArticleId IdType="pubmed">25111021</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. R.; King O. D.; Shorter J.; Gitler A. D. (2013) Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361&#x2013;372. 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Inukai Y.; Nonaka T.; Arai T.; Yoshida M.; Hashizume Y.; Beach T. G.; Buratti E.; Baralle F. E.; Akiyama H.; Hisanaga S.; Hasegawa M. (2008) Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 582, 2899&#x2013;2904. 10.1016/j.febslet.2008.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.07.027</ArticleId><ArticleId IdType="pubmed">18656473</ArticleId></ArticleIdList></Reference><Reference><Citation>Langhorst M. F.; Genisyuerek S.; Stuermer C. A. (2006) Accumulation of FlAsH/Lumio Green in active mitochondria can be reversed by beta-mercaptoethanol for specific staining of tetracysteine-tagged proteins. Histochem. Cell Biol. 125, 743&#x2013;747. 10.1007/s00418-005-0136-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-005-0136-3</ArticleId><ArticleId IdType="pubmed">16395611</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiina Y.; Toyoda T.; Kawasoe Y.; Tateno S.; Shirai T.; Matsuo K.; Mizuno Y.; Ai T.; Niwa K. (2011) The prevalence and risk factors for cholelithiasis and asymptomatic gallstones in adults with congenital heart disease. Int. J. Cardiol. 152, 171&#x2013;176. 10.1016/j.ijcard.2010.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2010.07.011</ArticleId><ArticleId IdType="pubmed">20675000</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyfried N. T.; Gozal Y. M.; Dammer E. B.; Xia Q.; Duong D. M.; Cheng D.; Lah J. J.; Levey A. I.; Peng J. (2010) Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol. Cell. Proteomics 9, 705&#x2013;718. 10.1074/mcp.M800390-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M800390-MCP200</ArticleId><ArticleId IdType="pmc">PMC2860236</ArticleId><ArticleId IdType="pubmed">20047951</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M.; Romano V.; Avendano-Vazquez S. E.; Bembich S.; Buratti E.; Baralle F. E. (2012) Role of selected mutations in the Q/N rich region of TDP-43 in EGFP-12xQ/N-induced aggregate formation. Brain Res. 1462, 139&#x2013;150. 10.1016/j.brainres.2012.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.031</ArticleId><ArticleId IdType="pubmed">22406069</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R.; Yang G.; Nonaka T.; Arai T.; Jia W.; Cynader M. S. (2013) Reducing TDP-43 aggregation does not prevent its cytotoxicity. Acta Neuropathol. Commun. 1, 49.10.1186/2051-5960-1-49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-49</ArticleId><ArticleId IdType="pmc">PMC3893365</ArticleId><ArticleId IdType="pubmed">24252504</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A. K.; Soo K. Y.; Sundaramoorthy V.; Parakh S.; Ma Y.; Farg M. A.; Wallace R. H.; Crouch P. J.; Turner B. J.; Horne M. K.; Atkin J. D. (2013) ALS-Associated TDP-43 Induces Endoplasmic Reticulum Stress, Which Drives Cytoplasmic TDP-43 Accumulation and Stress Granule Formation. PLoS One 8, e81170.10.1371/journal.pone.0081170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081170</ArticleId><ArticleId IdType="pmc">PMC3843686</ArticleId><ArticleId IdType="pubmed">24312274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M.; Arai T.; Nonaka T.; Kametani F.; Yoshida M.; Hashizume Y.; Beach T. G.; Buratti E.; Baralle F.; Morita M.; Nakano I.; Oda T.; Tsuchiya K.; Akiyama H. (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60&#x2013;70. 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M.; Kwong L. K.; Lee E. B.; Kremmer E.; Flatley A.; Xu Y.; Forman M. S.; Troost D.; Kretzschmar H. A.; Trojanowski J. Q.; Lee V. M. (2009) Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137&#x2013;149. 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E. B.; Lee V. M.; Trojanowski J. Q. (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 13, 38&#x2013;50. 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>